Compare Vaxcyte Inc. Common Stock (PCVX) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Ulta Beauty Inc — how do they compare? Vaxcyte Inc. Common Stock trades at $67.75 (market cap $10.63B), while Ulta Beauty Inc trades at $599.23 (market cap $25.33B). The key difference: Ulta Beauty Inc is far larger — about 2.4× Vaxcyte Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Ulta Beauty Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Ulta Beauty Inc for 92 Days on average.
| PCVX | ULTA | |
|---|---|---|
Market Cap | $10.63B | $25.33B |
Volume | 1,525,205 | 603,913 |
Sector | Health | Consumer Cyclical |
52-Week High | $73.82 | $706.82 |
52-Week Low | $40.32 | $450.75 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $9.26B | $27.64B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ULTA stock trades at $579.00, up 2.03% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 outlook, driven by e-commerce momentum. Valuation metrics show a P/E of 21.57 and robust profitability with a 46.12% ROE. The stock is near its R1 resistance at $574, with overall sentiment positive but noting margin pressures.
Outlook is positive with a consensus price target of $624.93, implying upside, but risks include flat traffic, promotional pressures, and margin compression. Long-term growth is supported by expansion into wellness and international markets, though near-term execution remains key.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
